Integrated analysis identifies GABRB3 as a biomarker in prostate cancer

Integrated analysis identifies GABRB3 as a biomarker in prostate cancer

Abstract Background Treatment failure following androgen deprivation therapy (ADT) presents a significant challenge in the management of advanced prostate cancer. Thus, understanding the genetic factors influencing this process could facilitate the development of personalized treatments and innovati...

Full description

Bibliographic Details
Main Authors: Jun-Yan Chen, Chi-Fen Chang, Shu-Pin Huang, Chao-Yuan Huang, Chia-Cheng Yu, Victor C. Lin, Jiun-Hung Geng, Chia-Yang Li, Te-Ling Lu, Bo-Ying Bao
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Medical Genomics
Subjects:
PI3K/AKT pathway
GABRB3
Prostate cancer
Survival
Gene set enrichment analysis
Online Access:https://doi.org/10.1186/s12920-024-01816-8

Internet

https://doi.org/10.1186/s12920-024-01816-8

Similar Items